Pulmonx Corp Files 8-K on Security Holder Vote

TL;DR

Pulmonx shareholders voted on something important May 17th. Details TBD.

AI Summary

Pulmonx Corporation filed an 8-K on May 17, 2024, to report matters submitted to a vote of its security holders. The filing does not contain details about the specific proposals voted on or the outcome of the vote.

Why It Matters

This filing indicates that Pulmonx Corporation held a vote of its shareholders, which could pertain to important corporate governance matters or strategic decisions.

Risk Assessment

Risk Level: low — The filing is a standard procedural report of a shareholder vote without immediate financial implications or disclosed risks.

Key Players & Entities

• Pulmonx Corporation (company) — Registrant
• May 17, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value LUNG The Nasdaq Stock Market

Filing Documents

• lung-20240517.htm (8-K) — 37KB
• 0001127537-24-000057.txt ( ) — 158KB
• lung-20240517.xsd (EX-101.SCH) — 2KB
• lung-20240517_lab.xml (EX-101.LAB) — 21KB
• lung-20240517_pre.xml (EX-101.PRE) — 12KB
• lung-20240517_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On May 16, 2024, Pulmonx Corporation (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 34,386,725 shares of the Company's common stock were present or represented by proxy at the Annual Meeting, which represented approximately 88.59% of the Company's 38,811,830 shares of common stock that were outstanding and entitled to vote at the meeting as of the record date of March 20, 2024. At the Annual Meeting, the stockholders of the Company considered the three proposals outlined below, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 5, 2024 (the "Proxy Statement"). Proposal 1 – Election of Directors The stockholders elected each of the two nominees for Class I director to serve until the Company's 2027 Annual Meeting of Stockholders and until their successor has been elected and qualified. The voting results were as follows: For Withheld Broker Non-Votes Glendon E. French 16,898,796 13,685,328 3,802,601 Tiffany Sullivan 16,725,724 13,858,350 3,802,601 Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The voting results were as follows: For Against Abstain 34,338,117 38,937 9,671 There were no broker non-votes with respect to Proposal 2. Proposal 3 – Non-Binding Advisory Vote to Approve the Company's Executive Compensation The stockholders approved, on a non-binding advisory basis, the Company's executive compensation as disclosed in the Proxy Statement. The voting results were as follows: For Against Abstain Broker Non-Votes 16,307,204 14,268,198 8,722 3,802,601

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pulmonx Corporation Dated: May 17, 2024 By: /s/ David Lehman David Lehman General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR